Finasteride Figure 1 (Finasteride Fig.1)
Finasteride Tablet, Film Coated
Product Images NDC 67877-288
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 8 technical images submitted to the FDA as part of the official labeling for Finasteride (NDC 67877-288). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Ascend Laboratories, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Product Images & Figures Index
Finasteride-fig.2 (Finasteride Fig.2)
This seems to be a table or a graph with data regarding two groups (placebo and finasteride) and their results over a period of time. The percentages seem to refer to some kind of rate, but without more context or clearer formatting, it's hard to determine what the data represents.*
Finasteride Figure 2 (Finasteride Fig.3)
The text describes a table with data about the mean percent change from baseline with 1 SE for Placebo and Finasteride for over 4 years. The table shows the baseline values for both groups at 155 and 157 respectively. It then goes on to show the mean percent change from baseline for the next 4 years. The data suggests that Finasteride has lower values compared to Placebo, indicating that it may have a positive effect on the subject matter.*
Finasteride Figure 4 (Finasteride Fig.4)
This appears to be a graph with a percentage scale on the y-axis and years on the x-axis. The percentage appears to range from 0-40%, with a specific value of 25% indicated. The x-axis is labeled as "Years from Randomization". Without additional context or information, it is difficult to determine what the graph represents or what event is being referred to.*
Structutre (Finasteride Structure)
Fig 3finasteride
This text appears to be a graph illustrating the effects of Finasteride compared to a placebo on patients over a period of several months. The percentage of patients experiencing events is shown on the y-axis while the observation time in months is shown on the x-axis. The Finasteride group appears to have a lower percentage of events compared to the Placebo group, indicating that Finasteride may be an effective treatment.*
Finasteride 10s Carton2
Finasteride Tablets, USP are a medication that should not be used by women or children. It comes in tablet form, with 5mg per tablet. These tablets should not be handled by pregnant women or those who may become pregnant. It is manufactured by A Laboratories and distributed by Ascend Laboratories. The recommended adult dosage is 5mg once a day. It is to be kept in original packaging and protected from light.*
Finasteride-30 Counts (Finasteride 30)
Each film-coated tablet of Finasteride contains 5mg of USP. The tablets should be stored at room temperature between 20°C to 25°C in a tightly closed container and protected from light. The recommended dosage for adults is one tablet daily. Finasteride Tablets should not be used by women or children, especially those who are pregnant. Crushing or breaking the tablets is also not advisable. The product is manufactured by Akem Laboratoires Ltd in Mumbai, India, and distributed by Ascend Laboratories LLC. The accompanying circular should be read carefully.*
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.
